Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01142323 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Fenofibrate for PSC
A Phase 1 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01142323 is a Phase 1 study that was terminated before completion, run by University of Miami. The registered enrollment target is 8 participants.
The verdict
NCT01142323, a Phase 1 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).
Interventions
- DRUG fenofibrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01142323
The ClinicalTrials.gov registry entry for NCT01142323 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fenofibrate is the first listed.
NCT01142323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01142323 about?
NCT01142323 is a clinical study titled "Pilot Study of Fenofibrate for PSC". The purpose of this study is to determine whether fenofibrate is safe and effective in the treatment primary sclerosing cholangitis (PSC).
What is the current status of trial NCT01142323?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2010-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01142323?
The interventions under investigation include: fenofibrate (DRUG).
Who is sponsoring clinical trial NCT01142323?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.